Miller Michael Patrick insider trades
Miller Michael Patrick has filed 16 Form 4s with the SEC that we hold, for Puma Biotechnology, INC. (PBYI) (Director), BioXcel Therapeutics, Inc. (BTAI) (Director) and Rigel Pharmaceuticals INC (RIGL) (Director). Across all of them we count 0 purchases worth $0 and 6 sales worth $456.6K reported on Form 4. In the last 12 months: 0 purchases ($0) and 1 sale ($97.2K). The largest single trade was a sale of 20,000 shares of Puma Biotechnology, INC. worth $97.2K, dated 2025-11-11. The first filing on our record is dated 2022-03-17 and the latest 2026-06-15.
Puma Biotechnology, INC. (PBYI)
| Trade date | Code | Shares | Value as filed | Filed |
|---|---|---|---|---|
| 2022-03-16 | S, sale reported on Form 4 | 25,653 | $71.8K | 2022-03-17 |
| 2022-08-09 | S, sale reported on Form 4 | 25,000 | $88.8K | 2022-08-10 |
| 2023-06-13 | S, sale reported on Form 4 | 13,500 | $46.6K | 2023-06-15 |
| 2023-11-07 | S, sale reported on Form 4 | 25,000 | $70.8K | 2023-11-09 |
| 2024-08-12 | S, sale reported on Form 4 | 23,358 | $81.5K | 2024-08-13 |
| 2025-11-11 | S, sale reported on Form 4 | 20,000 | $97.2K | 2025-11-13 |
BioXcel Therapeutics, Inc. (BTAI)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Rigel Pharmaceuticals INC (RIGL)
No purchase or sale of common stock reported here; these filings cover grants, option exercises or other codes.
Counted from the Form 4 filings this reporting owner (SEC CIK 1236514) filed on EDGAR. Values are the transaction values as filed. See every filing on EDGAR, or browse insider buying and today's insider purchases.
Source: U.S. Securities and Exchange Commission (EDGAR) and other official
government data · Updated 2026-10-12 ·
For informational purposes only, not investment advice.
Privacy · Terms